ERK1/2-Nanog signaling pathway enhances CD44(+) cancer stem-like cell phenotypes and epithelial-to-mesenchymal transition in head and neck squamous cell carcinomas.
- DOI
- 10.1038/s41419-020-2448-6
- Published
- 2020 Apr 23
- Container
- Cell death & disease
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41419-020-2448-6,
title = {ERK1/2-Nanog signaling pathway enhances CD44(+) cancer stem-like cell phenotypes and epithelial-to-mesenchymal transition in head and neck squamous cell carcinomas.},
author = {Huang C and Yoon C and Zhou XH and Zhou YC and Zhou WW and Liu H and Yang X and Lu J and Lee SY and Huang K},
year = {2020},
journal = {Cell death \& disease},
doi = {10.1038/s41419-020-2448-6},
url = {https://doi.org/10.1038/s41419-020-2448-6}
}RIS
TY - JOUR TI - ERK1/2-Nanog signaling pathway enhances CD44(+) cancer stem-like cell phenotypes and epithelial-to-mesenchymal transition in head and neck squamous cell carcinomas. AU - Huang C AU - Yoon C AU - Zhou XH AU - Zhou YC AU - Zhou WW AU - Liu H AU - Yang X AU - Lu J AU - Lee SY AU - Huang K PY - 2020 JO - Cell death & disease DO - 10.1038/s41419-020-2448-6 UR - https://doi.org/10.1038/s41419-020-2448-6 ER -
APA
C, H., C, Y., XH, Z., YC, Z., WW, Z., H, L., X, Y., J, L., SY, L., & K, H. (2020). ERK1/2-Nanog signaling pathway enhances CD44(+) cancer stem-like cell phenotypes and epithelial-to-mesenchymal transition in head and neck squamous cell carcinomas.. Cell death & disease. https://doi.org/10.1038/s41419-020-2448-6
Source records
- pubmed · retrieved 2026-09-26T05:31:28.499Z